TRPM4, a sodium-permeable channel, likely drives metastasis through calcium signaling dysregulation, while SLC9A1, a sodium-hydrogen exchanger, may acidify the tumor microenvironment to promote therapy resistance. Here, TRPM4 is linked to neoplasm.